Homestead, FLNCT06920004Now EnrollingIRB Ready

Chronic Inflammatory Demyelinating Polyneuropathy Clinical Trial in Homestead, FL

Access cutting-edge chronic inflammatory demyelinating polyneuropathy treatment through this clinical trial at a research site in Homestead. Study-provided care at no cost to qualified participants.

Sponsored by argenx

Quick Self-Assessment

See if you qualify for this Homestead location

Preparing your pre-screening questions…

Expert Care in Homestead

Access chronic inflammatory demyelinating polyneuropathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic inflammatory demyelinating polyneuropathy treatment provided free

Apply for This Homestead Location

Check if you qualify for this chronic inflammatory demyelinating polyneuropathy clinical trial in Homestead, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Homestead

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Homestead site if eligible
  4. 4Begin participation

About This Chronic Inflammatory Demyelinating Polyneuropathy Study in Homestead

The main purpose of this study is to compare empasiprubart and IVIg for treating people with CIDP. This study consists of a Part A where participants will either receive empasiprubart and a placebo resembling IVIg, or IVIg and a placebo resembling empasiprubart for 24 weeks (6 months). Following Part A, participants will enter Part B in which all participants will receive empasiprubart for 96 weeks (24 months). More information can be found here: https://clinicaltrials.argenx.com/emvigorate

Sponsor: argenx

Who Can Participate

Inclusion Criteria

Meets criteria for CIDP based on EAN/PNS Task Force CIDP guidelines, second revision (2021)
Has either typical CIDP or 1 of the following CIDP variants: motor CIDP, multifocal CIDP (also known as Lewis-Sumner syndrome), focal CIDP, or distal CIDP
Has responded to IVIg in the past 5 years
Receiving treatment with IVIg within a standard optimal maintenance dosing regimen, with a minimum weekly IVIg dose of at least 0.125 g/kg
Has residual disability and active disease

Exclusion Criteria

Besides the indication under study, known autoimmune disease or any medical condition that would interfere with an accurate assessment of clinical symptoms of CIDP or puts the participant at undue risk, including polyneuropathy of other causes
Meets the criteria for possible or sensory CIDP based on EAN/PNS Task Force CIDP guidelines, second revision (2021)
Use of other long-acting immunomodulatory treatment

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Homestead?

Yes, this clinical trial (NCT06920004) has an active research site in Homestead, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Inflammatory Demyelinating Polyneuropathy Treatment Options in Homestead, FL

If you're searching for chronic inflammatory demyelinating polyneuropathy treatment options in Homestead, FL, this clinical trial (NCT06920004) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Homestead research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic inflammatory demyelinating polyneuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic inflammatory demyelinating polyneuropathy clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Homestead, FL

See all multiple myeloma clinical trials recruiting in Homestead — not just this study.

Browse Multiple Myeloma Trials in Homestead

Ready to Join in Homestead?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Homestead, FL